Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

352
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
352
Seizures: Classification01:13

Seizures: Classification

663
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
663
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

338
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
338
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

783
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
783
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

736
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
736
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

582
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
582

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validation of deep learning enabled software MetronMind to measure vertebral heart size and vertebral left atrial size in dogs.

PloS one·2026
Same author

Cenobamate: An Appraisal Five Years On.

Neurology and therapy·2026
Same author

Perspectives on the burden of drug-resistant epilepsy and treatment priorities: Findings from a multistakeholder survey.

Epilepsia open·2026
Same author

Transcription Factor Binding and Individual Genetic Risk of Valproate Teratogenicity.

Neurology·2026
Same author

Genome-wide association meta-analyses of drug-resistant epilepsy.

EBioMedicine·2025
Same author

Two-year mortality and seizure recurrence following status epilepticus in Auckland, New Zealand: A prospective cohort study.

Seizure·2024
Same journal

Neurological signs of possible diagnostic value in the cognitive clinic: past, present and future.

Practical neurology·2026
Same journal

Longitudinally extensive myelitis in neurosarcoidosis.

Practical neurology·2026
Same journal

Patient with bilateral horizontal gaze palsy.

Practical neurology·2026
Same journal

Orofacial pain beyond trigeminal neuralgia.

Practical neurology·2026
Same journal

Are all antibody panels equal?

Practical neurology·2026
Same journal

Management of subdural haematoma: a practical guide.

Practical neurology·2026
See all related articles

Related Experiment Video

Updated: Oct 10, 2025

Author Spotlight: Obtaining High-Quality CSF and Blood Samples for Epilepsy Biomarker Discovery
10:46

Author Spotlight: Obtaining High-Quality CSF and Blood Samples for Epilepsy Biomarker Discovery

Published on: September 1, 2023

3.5K

Epilepsy and pregnancy: identifying risks.

John J Craig1, Shona Scott2, John Paul Leach3

  • 1Neurology, Belfast Health and Social Care Trust, Belfast, UK.

Practical Neurology
|December 10, 2021
PubMed
Summary
This summary is machine-generated.

Managing epilepsy during pregnancy requires balancing risks of seizures and medication side effects. This review guides clinicians in preventing complications for both mother and child, focusing on high-risk individuals.

Keywords:
anticonvulsantsepilepsyobstetricssudden death

More Related Videos

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

2.9K
Stereo-Electro-Encephalo-Graphy SEEG With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note
05:54

Stereo-Electro-Encephalo-Graphy SEEG With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note

Published on: June 13, 2016

17.4K

Related Experiment Videos

Last Updated: Oct 10, 2025

Author Spotlight: Obtaining High-Quality CSF and Blood Samples for Epilepsy Biomarker Discovery
10:46

Author Spotlight: Obtaining High-Quality CSF and Blood Samples for Epilepsy Biomarker Discovery

Published on: September 1, 2023

3.5K
Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

2.9K
Stereo-Electro-Encephalo-Graphy SEEG With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note
05:54

Stereo-Electro-Encephalo-Graphy SEEG With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note

Published on: June 13, 2016

17.4K

Area of Science:

  • Neurology
  • Obstetrics
  • Maternal-Fetal Medicine

Background:

  • Pregnancy presents unique physical, physiological, and psychological challenges.
  • Women with epilepsy face additional risks during pregnancy, impacting maternal and fetal well-being.
  • Effective management necessitates balancing seizure control with potential treatment side effects.

Purpose of the Study:

  • To review current evidence on epilepsy management in pregnant women.
  • To identify the effects of epilepsy and its treatments on pregnancy outcomes.
  • To outline strategies for reducing obstetric and fetal complications.

Main Methods:

  • Literature review of epilepsy management during pregnancy.
  • Analysis of effects on gestation, fetal development, and neurocognition.
  • Identification of risk factors and preventative strategies.

Main Results:

  • Epilepsy and its treatment can affect fetal development and neurocognitive outcomes.
  • Strategies exist to mitigate obstetric and fetal risks.
  • Risk stratification is crucial for tailored management.

Conclusions:

  • Optimizing epilepsy care during pregnancy involves careful risk-benefit assessment.
  • Proactive management and identification of high-risk patients are essential.
  • Ensuring a healthy pregnancy, delivery, and motherhood for women with epilepsy is achievable with evidence-based strategies.